According to WiseGuy Reports, the Methylating Agent Market reached USD 7.59 Billion in 2024 and is anticipated to expand to USD 10.5 Billion by 2032, registering a CAGR of 4.14% from 2024 to 2032. The market is gaining momentum from increased cancer research, advances in epigenetics, growing interest in personalized medicine, and the wider use of methylation analysis in pharmaceutical and...